https://mma.prnewswire.com/media/405060/Rosen_Law_Logo.jpg Why:Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Viatris Inc. (NASDAQ: VTRS) between August 8, 2024 and February 26, 2025, both dates inclusive (the “Class Period”), of the importantJune 3, 2025 lead plaintiff deadline. So what: If you purchased Viatris securitiesduring the Class Period you may be entitled […]

BERLIN, June 01, 2025 (GLOBE NEWSWIRE) — After more than 15 years operating quietly under the name BERGER KOMMUNIKATION, one of Europe's most trusted backend communication infrastructures has officially rebranded and relaunched as KONTAKTUM. KONTAKTUM will now operate independently, with a sharpened focus on the wellness and health supplement industry across the EU. The new

KONTAKTUM (former Berger Kommunkation) launches SignalDesk to Power Europe's Top Wellness Brands GlobeNewswire June 01, 2025 BERLIN, June 01, 2025 (GLOBE NEWSWIRE) — After more than 15 years operating quietly under the name BERGER KOMMUNIKATION, one of Europe's most trusted backend communication infrastructures has officially rebranded and relaunched as KONTAKTUM. KONTAKTUM will now operate independently,

(NYSE:ELV), NEW YORK, June 01, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Elevance Health, Inc. (NYSE: ELV) between April 18, 2024 and October 16, 2024, both dates inclusive (the “Class Period”), of the important July 11, 2025 lead plaintiff deadline. SO WHAT:

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Elevance Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELV GlobeNewswire June 01, 2025 NEW YORK, June 01, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Elevance Health, Inc. (NYSE: ELV) between

CDPQ acknowledges the significant contribution of Marc-André Blanchard, Executive Vice-President and Head of CDPQ Global and Global Head of Sustainability, who announced today his departure to take on the role of Chief of Staff to the Prime Minister of Canada, Mr. Mark Carney. Arriving at CDPQ in 2020, Marc-André Blanchard has profoundly impacted the organization.

(NasdaqGM:BCAX), Median DOR of 21.7 months with 80% of responders achieving a deep response (greater-than or equal to80% tumor shrinkage) Depth and durability translating to prolonged OS with median OS of 21.3 months and 2-year OS of 46% in HPV-negative HNSCC Conference call and webcast today at 3:00 p.m. CT / 4:00 p.m. ET BOSTON,

Bicara Therapeutics Demonstrates Deep and Durable Responses with Ficerafusp Alfa Plus Pembrolizumab in 1L HPV-Negative R/M HNSCC at ASCO 2025 GlobeNewswire June 01, 2025 Median DOR of 21.7 months with 80% of responders achieving a deep response (greater-than or equal to80% tumor shrinkage) Depth and durability translating to prolonged OS with median OS of 21.3

NEW YORK, NY / ACCESS Newswire / June 1, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/zenas-biopharma-inc-lawsuit-submission-form?prid=151178&wire=1&utm_campaign=24 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESS Newswire / June 1, 2025 / If you suffered a loss on your Organon & Co. (NYSE:OGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/organon-co-lawsuit-submission-form?prid=151176&wire=1&utm_campaign=2 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or